Work overview
10 items found
Project
01 January 1970
A costimulatory power-boost for HIV-specific T-cells through GITR activation
People infected with HIV have nowadays almost the average life expectancy of the...
Project
01 January 1970
Activation of latent HIV virus
HIV therapy keeps the virus under control, but does not provide a cure. One caus...
Project
01 January 1970
Development of a natural drug 'mimic' derived from dendritic cells that activate latent HIV-1 and potentially could cure infected patients
HIV-1 can infect cells from the immune system without producing new viruses. The...
Project
01 January 1970
HIV envelope trimer vaccines that engage desirable germline antibodies
Despite 30 years of intensive research, an effective HIV-1 vaccine remains elusi...
Project
01 January 1970
Investigation of the central nervous system as a potential HIV reservoir during combination antiretroviral therapy.
The major obstacle to HIV cure is presence of a stable reservoir of latently inf...
Project
01 January 1970
Langerhans cell antiviral mechanisms control HIV
AMC researcher, Theo Geijtenbeek, previously discovered that certain immune cell...
Project
01 January 1970
Research on HIV latency in the viral reservoir
Dr. Monique Nijhuis aims to characterize the latently HIV-infected viral reservo...
Project
01 January 1970
Role of dendritic cells in HIV response
Dentritic cells play an important role in the immune system. As soon as a pathog...
Project
01 January 1970
Targeting BAF complex to reverse HIV latency
There is no drug that can cure HIV. The HIV virus can become latent and therefor...
Project
01 January 1970
The FIND study: core-needle biopsies to detect the hidden HIV reservoirs in hard-to-reach tissue compartments of well-controlled and uncontrolled HIV-patients
The major obstacle to an HIV cure is the presence of a persistent viral reservoi...